Cargando…
Impact of Dapagliflozin on the Left Ventricular Diastolic Function in Diabetic Patients with Heart Failure Complicating Cardiovascular Risk Factors
OBJECTIVE: Our aim was to investigate the impact of the sodium glucose cotransporter type 2 (SGLT2) inhibitor on the left ventricular (LV) diastolic function in type 2 diabetes mellitus (T2DM) patients with chronic heart failure (HF) complicating cardiovascular risk factors. METHODS: We analyzed dat...
Autores principales: | Soga, Fumitaka, Tanaka, Hidekazu, Tatsumi, Kazuhiro, Mochizuki, Yasuhide, Sano, Hiroyuki, Toki, Hiromi, Matsumoto, Kensuke, Shite, Junya, Takaoka, Hideyuki, Doi, Tomofumi, Hirata, Ken-ichi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Japanese Society of Internal Medicine
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8381170/ https://www.ncbi.nlm.nih.gov/pubmed/34334588 http://dx.doi.org/10.2169/internalmedicine.6127-20 |
Ejemplares similares
-
Impact of dapagliflozin on left ventricular diastolic function of patients with type 2 diabetic mellitus with chronic heart failure
por: Soga, Fumitaka, et al.
Publicado: (2018) -
Positive effect of dapagliflozin on left ventricular longitudinal function for type 2 diabetic mellitus patients with chronic heart failure
por: Tanaka, Hidekazu, et al.
Publicado: (2020) -
Association of glycemic variability with left ventricular diastolic function in type 2 diabetes mellitus
por: Yokota, Shun, et al.
Publicado: (2019) -
Clinical features of subclinical left ventricular systolic dysfunction in patients with diabetes mellitus
por: Mochizuki, Yasuhide, et al.
Publicado: (2015) -
Association of peripheral nerve conduction in diabetic neuropathy with subclinical left ventricular systolic dysfunction
por: Mochizuki, Yasuhide, et al.
Publicado: (2015)